Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kera-Diet is a biotechnology initiative focused on the development of high-protein dietary supplements derived from keratinous waste materials, such as feathers and hair. The company utilizes specialized microbial and enzymatic processes to convert indigestible keratin into highly bioavailable peptides and amino acids. Their primary goal is to address global protein malnutrition by providing a sustainable and cost-effective nutritional source. The technology aims to transform industrial by-products into value-added functional foods and therapeutic grade protein supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kera-Diet developers.